Heart Test Laboratories, Inc. Quarterly Debt-to-equity in % from Q4 2022 to Q2 2024

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Heart Test Laboratories, Inc. quarterly Debt-to-equity history and growth rate from Q4 2022 to Q2 2024.
  • Heart Test Laboratories, Inc. Debt-to-equity for the quarter ending July 31, 2024 was 52.5 %, a 97.9% decline year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q2 2024 52.5 -2.49K -97.9% Jul 31, 2024
Q1 2024 83.4 -251 -75% Apr 30, 2024
Q4 2023 185 +963 Jan 31, 2024
Q3 2023 -634 Oct 31, 2023
Q2 2023 2.54K Jul 31, 2023
Q1 2023 334 Apr 30, 2023
Q4 2022 -779 Jan 31, 2023
* An asterisk sign (*) next to the value indicates that the value is likely invalid.